Oregon Public Employees Retirement Fund’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $126K | Buy |
15,481
+100
| +0.7% | +$814 | ﹤0.01% | 1468 |
|
2025
Q1 | $121K | Buy |
15,381
+2,700
| +21% | +$21.2K | ﹤0.01% | 1474 |
|
2024
Q4 | $189K | Hold |
12,681
| – | – | ﹤0.01% | 1426 |
|
2024
Q3 | $194K | Sell |
12,681
-600
| -5% | -$9.17K | ﹤0.01% | 1417 |
|
2024
Q2 | $202K | Sell |
13,281
-1,200
| -8% | -$18.3K | ﹤0.01% | 1384 |
|
2024
Q1 | $273K | Sell |
14,481
-1,300
| -8% | -$24.5K | 0.01% | 1339 |
|
2023
Q4 | $301K | Sell |
15,781
-127
| -0.8% | -$2.43K | 0.01% | 1364 |
|
2023
Q3 | $286K | Sell |
15,908
-500
| -3% | -$8.98K | ﹤0.01% | 1478 |
|
2023
Q2 | $333K | Sell |
16,408
-400
| -2% | -$8.12K | ﹤0.01% | 1448 |
|
2023
Q1 | $307K | Sell |
16,808
-531
| -3% | -$9.69K | ﹤0.01% | 1474 |
|
2022
Q4 | $359K | Buy |
17,339
+78
| +0.5% | +$1.61K | ﹤0.01% | 1425 |
|
2022
Q3 | $452K | Buy |
17,261
+1,961
| +13% | +$51.4K | 0.01% | 1302 |
|
2022
Q2 | $388K | Buy |
+15,300
| New | +$388K | 0.01% | 1230 |
|